The success of Sildenafil initially drove a surge for the drug industry, however recent changes present a complicated scenario for investors. Lower-cost competitors are reducing revenue, and persistent legal battles https://royzyor097177.dailyblogzz.com/41665679/the-blue-pill-and-big-pharma-a-precarious-investment